Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 0. It has been cited 555 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01CA200707
NIH
Grant: GM008497
NIH
Grant: 25A5072
University of Colorado Cancer Center
Grant: P30CA046934
NHLBI NIH HHS
Grant: R01 HL148151
NHLBI NIH HHS
Grant: T32 HL007171
NHLBI NIH HHS
Grant: R01 HL146442
NIGMS NIH HHS
Grant: T32 GM008497
NIAID NIH HHS
Grant: T32 AI074491
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5T32GM008497-04
INSTITUTIONAL NATIONAL RESEARCH TRAINING AWARD
National Institutes of Health
Grant: 5R01CA200707-05
Characterization and targeting of leukemia stem cell metabolism
University of Colorado
Department of Medicine Outstanding Early Career Scholar Program
Leukemia and Lymphoma Society
Blood Cancer UK
Boettcher Foundation
E.P. Evans Foundation Biff Ruttenberg Foundation
FWCI
29.86
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals